🇯🇵 Somatuline Depot in Japan

PMDA authorised Somatuline Depot on 12 December 2020

Marketing authorisation

PMDA — authorised 12 December 2020

  • Marketing authorisation holder: TEIJIN PHARMA LIMITED
  • Status: approved

Somatuline Depot in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in Japan

Frequently asked questions

Is Somatuline Depot approved in Japan?

Yes. PMDA authorised it on 12 December 2020.

Who is the marketing authorisation holder for Somatuline Depot in Japan?

TEIJIN PHARMA LIMITED holds the Japanese marketing authorisation.